Remus Pharmaceuticals Limited (NSE:REMUS)
683.40
+9.85 (1.46%)
At close: Oct 24, 2025
1.46% (1Y)
| Market Cap | 7.97B |
| Revenue (ttm) | 6.20B |
| Net Income (ttm) | 290.70M |
| Shares Out | 11.66M |
| EPS (ttm) | 24.67 |
| PE Ratio | 27.70 |
| Forward PE | n/a |
| Dividend | 0.75 (0.11%) |
| Ex-Dividend Date | Sep 18, 2025 |
| Volume | 1,600 |
| Average Volume | 4,700 |
| Open | 699.00 |
| Previous Close | 673.55 |
| Day's Range | 680.00 - 699.00 |
| 52-Week Range | 636.10 - 1,385.00 |
| Beta | 0.21 |
| RSI | 33.51 |
| Earnings Date | Nov 10, 2025 |